Literature DB >> 11454846

Magnesium causes nitric oxide independent coronary artery vasodilation in humans.

H Teragawa1, M Kato, T Yamagata, H Matsuura, G Kajiyama.   

Abstract

OBJECTIVE: To determine how magnesium affects human coronary arteries and whether endothelium derived nitric oxide (EDNO) is involved in the coronary arterial response to magnesium.
DESIGN: Quantitative coronary angiography and Doppler flow velocity measurements were used to determine the effects of the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine (L-NMMA) on magnesium induced dilation of the epicardial and resistance coronary arteries.
SETTING: Hiroshima University Hospital a tertiary cardiology centre. PATIENTS: 17 patients with angiographically normal coronary arteries.
INTERVENTIONS: Magnesium sulfate (MgSO(4)) (0.02 mmol/min and 0.2 mmol/min) was infused for two minutes into the left coronary ostium before and after intracoronary infusion of L-NMMA. MAIN OUTCOME MEASURES: Diameter of the proximal and distal segments of the epicardial coronary arteries and coronary blood flow.
RESULTS: At a dose of 0.02 mmol/min, MgSO(4) did not affect the coronary arteries. At a dose of 0.2 mmol/min, MgSO(4) caused coronary artery dilation (mean (SEM) proximal diameter 3.00 (0.09) to 3.11 (0.09) mm; distal 1.64 (0.06) to 1.77 (0.07) mm) and increased coronary blood flow (79.3 (7.5) to 101.4 (9.9) ml/min, p < 0.001 v baseline for all). MgSO(4) increased the changes in these parameters after the infusion of L-NMMA (p < 0.001 v baseline).
CONCLUSIONS: Magnesium dilates both the epicardial and resistance coronary arteries in humans. Furthermore, the coronary arterial response to magnesium is dose dependent and independent of EDNO.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454846      PMCID: PMC1729866          DOI: 10.1136/heart.86.2.212

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  37 in total

1.  Differential effects of magnesium on basal and agonist-induced EDRF relaxation in canine coronary arteries.

Authors:  D D Ku; H S Ann
Journal:  J Cardiovasc Pharmacol       Date:  1991-06       Impact factor: 3.105

2.  Intravenous magnesium in acute myocardial infarction. An effective, safe, simple, and inexpensive intervention.

Authors:  S Yusuf; K Teo; K Woods
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

3.  Reduction of pacing-induced myocardial ischemia by intravenous magnesium sulfate.

Authors:  C Vigorito; A Giordano; P Ferraro; P Supino; M De Pasquale; B Giordano; F Lionetti; F Rengo
Journal:  Am J Cardiol       Date:  1995-02-01       Impact factor: 2.778

4.  Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.

Authors:  A A Quyyumi; N Dakak; N P Andrews; S Husain; S Arora; D M Gilligan; J A Panza; R O Cannon
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

5.  Magnesium sulphate reverses the carotid vasoconstriction caused by endothelin-I, angiotensin II and neuropeptide-Y, but not that caused by NG-nitro-L-arginine methyl ester, in conscious rats.

Authors:  P A Kemp; S M Gardiner; T Bennett; P C Rubin
Journal:  Clin Sci (Lond)       Date:  1993-08       Impact factor: 6.124

6.  Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

Authors:  K L Woods; S Fletcher; C Roffe; Y Haider
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

7.  In vivo and in vitro magnesium effects on aortic prostacyclin generation in DOCA-salt hypertensive rats.

Authors:  P Laurant; C Moussard; D Alber; J C Henry; A Berthelot
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1992-11       Impact factor: 4.006

8.  Assessment of platelet cytosolic concentration of free magnesium in healthy subjects.

Authors:  M Yoshimura; T Oshima; H Matsuura; M Watanabe; Y Higashi; N Ono; H Hiraga; M Kanbe; G Kajiyama
Journal:  J Lab Clin Med       Date:  1995-06

9.  Effects of modified St Thomas' Hospital solution on coronary artery endothelium dependent relaxation in the isolated rat heart.

Authors:  R Cartier; C Hollmann; J Buluran; F Dagenais
Journal:  Can J Cardiol       Date:  1995-01       Impact factor: 5.223

10.  The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation.

Authors:  H Parikka; L Toivonen; T Pellinen; K Verkkala; A Järvinen; M S Nieminen
Journal:  Eur Heart J       Date:  1993-02       Impact factor: 29.983

View more
  13 in total

1.  Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia.

Authors:  Y Fukuda; H Teragawa; K Matsuda; T Yamagata; H Matsuura; K Chayama
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

2.  Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial.

Authors:  Oluwakemi Badaki-Makun; J Paul Scott; Julie A Panepinto; T Charles Casper; Cheryl A Hillery; J Michael Dean; David C Brousseau
Journal:  Pediatr Blood Cancer       Date:  2014-01-17       Impact factor: 3.167

3.  Nutrient-enhanced diet reduces noise-induced damage to the inner ear and hearing loss.

Authors:  Colleen G Le Prell; Patricia M Gagnon; David C Bennett; Kevin K Ohlemiller
Journal:  Transl Res       Date:  2011-03-21       Impact factor: 7.012

4.  Impaired coronary microvascular endothelial function in men with metabolic syndrome.

Authors:  Hiroki Teragawa; Naoya Mitsuba; Kenji Nishioka; Kentaro Ueda; Shingo Kono; Yukihito Higashi; Kazuaki Chayama; Yasuki Kihara
Journal:  World J Cardiol       Date:  2010-07-26

5.  History of gastroesophageal reflux disease in patients with suspected coronary artery disease.

Authors:  Hiroki Teragawa; Chikage Oshita; Tomohiro Ueda
Journal:  Heart Vessels       Date:  2019-04-16       Impact factor: 2.037

Review 6.  A feasibility study of using biodegradable magnesium alloy in glaucoma drainage device.

Authors:  Xiang-Ji Li; Lin Xie; Fu-Sheng Pan; Yong Wang; Hong Liu; Yu-Rong Tang; Cindy Ml Hutnik
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

7.  Relation between C reactive protein concentrations and coronary microvascular endothelial function.

Authors:  H Teragawa; Y Fukuda; K Matsuda; K Ueda; Y Higashi; T Oshima; M Yoshizumi; K Chayama
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

8.  Evaluation of coronary microvascular function in patients with vasospastic angina.

Authors:  Hiroki Teragawa; Naoya Mitsuba; Ken Ishibashi; Kenji Nishioka; Satoshi Kurisu; Yasuki Kihara
Journal:  World J Cardiol       Date:  2013-01-26

9.  A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.

Authors:  David C Brousseau; J Paul Scott; Oluwakemi Badaki-Makun; Deepika S Darbari; Corrie E Chumpitazi; Gladstone E Airewele; Angela M Ellison; Kim Smith-Whitley; Prashant Mahajan; Sharada A Sarnaik; T Charles Casper; Lawrence J Cook; J Michael Dean; Julie Leonard; Monica L Hulbert; Elizabeth C Powell; Robert I Liem; Robert Hickey; Lakshmanan Krishnamurti; Cheryl A Hillery; Mark Nimmer; Julie A Panepinto
Journal:  Blood       Date:  2015-07-31       Impact factor: 22.113

10.  Positive influence of aspirin on coronary endothelial function: Importance of the dose.

Authors:  Hiroki Teragawa; Naoya Mitsuba; Ken Ishibashi; Satoshi Kurisu; Yasuki Kihara
Journal:  World J Cardiol       Date:  2013-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.